Clinical trial
A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent…
NCT00480766 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00480766 |
|---|---|
| Title | A Research Study to Evaluate the Safety and Effectiveness of MK0217 to Prevent and Treat Bone Loss (0217-193)(COMPLETED) |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 12-Month Study to Evaluate the Efficacy and Safety of Oral Alendronate Sodium Once Weekly for the Prevention and Treatment of Glucocorticoid-Induced Bone Loss |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | MK0217/Duration of Treatment : 12 Months |
| Enrollment | 173 |
| Start date | Jul 1, 2001 |
| Primary completion | Aug 1, 2003 |
| Completion | Aug 1, 2003 |
| First posted | May 31, 2007 |
| Last update posted | Aug 14, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: